Home
>
National Drug Code (NDC)
>
Labetalol Hydrochloride
Labetalol Hydrochloride - 76237-261-30 - (Labetalol Hydrochloride)
Drug Information of Labetalol Hydrochloride
| Product NDC: | 76237-261 |
| Proprietary Name: | Labetalol Hydrochloride |
| Non Proprietary Name: | Labetalol Hydrochloride |
| Active Ingredient(s): | 200 mg/1 & nbsp; Labetalol Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Labetalol Hydrochloride
| Product NDC: | 76237-261 |
| Labeler Name: | McKesson Contract Packaging |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074787 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120321 |
Package Information of Labetalol Hydrochloride
| Package NDC: | 76237-261-30 |
| Package Description: | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (76237-261-30) > 5 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of Labetalol Hydrochloride
| NDC Code | 76237-261-30 |
| Proprietary Name | Labetalol Hydrochloride |
| Package Description | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (76237-261-30) > 5 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 76237-261 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120321 |
| Marketing Category Name | ANDA |
| Labeler Name | McKesson Contract Packaging |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
